Iridex (IRIX) Asset Writedowns and Impairment (2011 - 2025)
Iridex's (IRIX) quarterly Asset Writedowns and Impairment came in at $800000.0 in Q3 2025, up 892.08% quarter-over-quarter from -$101000.0 in Q1 2022.
Iridex (IRIX) Asset Writedowns and Impairment (2011 - 2025) Analysis & Trends
Iridex's Asset Writedowns and Impairment history runs 11 years deep, the most recent figure standing at $800000.0 for Q3 2025.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $800000.0 in Q3 2025; TTM through Jan 2026 was $800000.0, a 1350.0% increase from a year earlier, with the FY2026 full-year figure at $823000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment grew to $800000.0 in Q3 2025 per IRIX's latest filing, from -$101000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $800000.0 in Q3 2025 and bottomed at -$101000.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Iridex | 15.41 Mn | 10.81 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 27, 2025 | 800,000.00 |
| Sep 27, 2025 | 800,000.00 |
| Jan 1, 2022 | -101,000.00 |
| Jan 1, 2022 | -101,000.00 |
| Sep 26, 2020 | 37,000.00 |
| Sep 26, 2020 | 37,000.00 |
| Jun 27, 2020 | 59,000.00 |
| Jun 27, 2020 | 59,000.00 |
| Mar 28, 2020 | 42,000.00 |
| Mar 28, 2020 | 42,000.00 |
| Mar 30, 2019 | 25,000.00 |
| Mar 30, 2019 | 25,000.00 |
| Dec 30, 2017 | 39,000.00 |
| Dec 30, 2017 | 39,000.00 |
| Sep 30, 2017 | -14,000.00 |
| Sep 30, 2017 | -14,000.00 |
| Dec 31, 2016 | 120,000.00 |
| Dec 31, 2016 | 120,000.00 |
| Oct 1, 2016 | 25,000.00 |
| Oct 1, 2016 | 25,000.00 |